Arçelik Erases 6-Month Loss, Net Profit Rises to 1.5 Trillion TL – Target Prices Updated
724FinanceKerem Tufan
Key Highlights
Arçelik, 2026 yılının ilk yarısında **1,493,453,000 TL** net kar açıklayarak bir önceki yılın aynı dönemindeki **5,382,933,000 TL** net zararı geride

Arçelik posted a 1,493,453,000 TL net profit for the first half of 2026, wiping out the 5,382,933,000 TL net loss recorded in the same period last year.
Financial Turnaround: From Loss to Profit
Target Price Revisions and Market Reaction
Liquidity and Credit Outlook
Kerem Tufan – Director of Commercial Loans and Central Bank Policies: "Arçelik’s striking financial rebound reflects both a recovery in domestic demand and effective cost optimisation. The ongoing tightening of SME credit and the pace of commercial loan growth, shaped by macro‑prudent measures, force large manufacturers to manage liquidity prudently. The company’s new credit request presents a strategic opening for the banking sector to ease credit‑supply pressures. However, the durability of target‑price upgrades will hinge on external trade conditions and currency volatility."
Related News & Analysis
View All →
Norway’s July Oil Production Slump Sends Shockwaves Through European Energy Markets

British Banks Issue Stern Warning to New Finance Minister and Market Implications

HSBC’s Most Traded Shares: Smart Money Signals in the Markets

Halk Yatırım’s Trading Masterclass: Top 10 Most Traded Stocks Revealed for H1 2024

Borsa Istanbul Companies Announce Game-Changing New Partnerships and Investment Moves

BIST Imposes Short‑Sell Ban on Cem Zeytin and BJKAS Shares Under Volatility‑Based Measures
Latest Market News
All News →![[YYAPI] YEŞİL YAPI ENDÜSTRİSİ A.Ş.
Katılım Finansı İlkeleri Bilgi Formu - Katılım Finansı İlkeleri Bilgi Formu](/_next/image?url=%2Fuploads%2Fkap-default.png&w=3840&q=75)
[YYAPI] YEŞİL YAPI ENDÜSTRİSİ A.Ş. Katılım Finansı İlkeleri Bilgi Formu - Katılım Finansı İlkeleri Bilgi Formu

Moderna's Cancer Vaccine Euphoria Hits Profit-Taking Wall: $18 Billion Wipeout
Moderna’s Personalized mRNA Gamble: Oncology Revolution or Market Bubble?
![[GSRAY] GALATASARAY SPORTİF SINAİ VE TİCARİ YATIRIMLAR A.Ş.
Transfer Görüşmelerinin Sonuçlanması veya Sona Ermesi - Profesyonel Futbolcu Aleksei Batrakov Transferi Hakkında](/_next/image?url=%2Fuploads%2Fkap-default.png&w=3840&q=75)
[GSRAY] GALATASARAY SPORTİF SINAİ VE TİCARİ YATIRIMLAR A.Ş. Transfer Görüşmelerinin Sonuçlanması veya Sona Ermesi - Profesyonel Futbolcu Aleksei Batrakov Transferi Hakkında

Norway’s July Oil Production Slump Sends Shockwaves Through European Energy Markets
